A detailed history of Petix & Botte CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Petix & Botte CO holds 8,618 shares of ABBV stock, worth $1.51 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
8,618
Previous 8,618 -0.0%
Holding current value
$1.51 Million
Previous $1.48 Million 15.09%
% of portfolio
0.45%
Previous 0.42%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $666,990 - $778,894
4,309 Added 100.0%
8,618 $1.48 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $691,541 - $787,946
-4,327 Reduced 50.1%
4,309 $784,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $2,476 - $2,789
18 Added 0.21%
8,636 $1.34 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $570,985 - $710,554
4,309 Added 100.0%
8,618 $1.16 Million
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $55,562 - $63,727
414 Added 10.63%
4,309 $578,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $536,029 - $681,469
-3,895 Reduced 50.0%
3,895 $597,000
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $514,062 - $637,806
3,895 Added 100.0%
7,790 $1.26 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $413,927 - $523,738
-3,853 Reduced 49.73%
3,895 $527,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $412,193 - $467,901
3,874 Added 100.0%
7,748 $836,000
Q1 2021

May 24, 2021

SELL
$102.3 - $112.62 $396,310 - $436,289
-3,874 Reduced 50.0%
3,874 $419,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $396,310 - $436,289
3,874 Added 100.0%
7,748 $420,000
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $332,815 - $390,615
-3,874 Reduced 50.0%
3,874 $339,000
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $284,235 - $380,349
3,874 Added 100.0%
7,748 $381,000
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $12,900 - $19,558
200 Added 5.44%
3,874 $295,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $265,005 - $331,578
3,674 New
3,674 $325,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Petix & Botte CO Portfolio

Follow Petix & Botte CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petix & Botte CO, based on Form 13F filings with the SEC.

News

Stay updated on Petix & Botte CO with notifications on news.